<?xml version="1.0" encoding="UTF-8"?><rss version="2.0">
	<channel>
		<title>IR</title>
		<link>https://info.kinesciences.com</link>
		<description></description>
		
				<item>
			<title><![CDATA[[더벨] 카인사이언스, 방사익·조대호 각자대표 체제 '전환']]></title>
			<link><![CDATA[https://info.kinesciences.com/?kboard_content_redirect=129]]></link>
			<description><![CDATA[<p> </p>
<p><a href="https://www.thebell.co.kr/front/newsview.asp?key=202604070816460100108817">출처 : 더벨 - 카인사이언스, 방사익·조대호 각자대표 체제 '전환'</a></p>]]></description>
			<author><![CDATA[카인사이언스]]></author>
			<pubDate>Thu, 16 Apr 2026 02:00:46 +0000</pubDate>
			<category domain="https://info.kinesciences.com/?kboard_redirect=1"><![CDATA[News]]></category>
		</item>
				<item>
			<title><![CDATA[[메디칼타임즈] 카인사이언스, 방사익 대표 선임…2인 각자대표 체제 전환]]></title>
			<link><![CDATA[https://info.kinesciences.com/?kboard_content_redirect=128]]></link>
			<description><![CDATA[<p> </p>
<p><a href="https://www.medicaltimes.com/Main/News/NewsView.html?ID=1168122">출처 : 메디칼타임즈 - 카인사이언스, 방사익 대표 선임…2인 각자대표 체제 전환</a></p>]]></description>
			<author><![CDATA[카인사이언스]]></author>
			<pubDate>Thu, 16 Apr 2026 01:57:30 +0000</pubDate>
			<category domain="https://info.kinesciences.com/?kboard_redirect=1"><![CDATA[News]]></category>
		</item>
				<item>
			<title><![CDATA[신주발행공고]]></title>
			<link><![CDATA[https://info.kinesciences.com/?kboard_content_redirect=127]]></link>
			<description><![CDATA[<h5 style="font-family:'Noto Sans KR', sans-serif;color:rgb(27,33,26);text-align:center;"><strong>신 주 발 행 공 고</strong></h5><h5 style="font-family:'Noto Sans KR', sans-serif;color:rgb(27,33,26);text-align:center;"><strong></strong><span style="font-size:20px;">주식회사 카인사이언스는 상법 제416조에 의거 2026년 04월 14일 이사회에서 </span></h5><h5 style="font-family:'Noto Sans KR', sans-serif;color:rgb(27,33,26);text-align:center;"><span style="font-size:20px;">아래와 같이 신주발행을 결의하였으므로 상법 제418조에 따라 이를 공고합니다.</span></h5><h5 style="font-family:'Noto Sans KR', sans-serif;color:rgb(27,33,26);text-align:center;"><span style="font-size:20px;">– 아 래 –</span></h5><p style="margin:0px 0px 0.75em;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;"><span style="font-size:16px;">1. 신주식 발행의 건</span></p><p style="margin:0px 0px 0.75em;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;"><span style="font-size:16px;">1) 신주식의 종류와 수 : 기명식 보통주식 187,500주<br /></span><span style="font-size:16px;">2) 1주의 액면금액 : 금500원<br /></span><span style="font-size:16px;">3) 1주의 발행가액 : 금 8,000원 <br /></span><span style="font-size:16px;">4) 신주 청약일 : 2026년 04월 29일 <br /></span><span style="font-size:16px;">5) 납 입 기 일 : 2026년 04월 29일 <br /></span><span style="font-size:16px;">6) 신주식의 인수방법 : 정관 제10조 2항 6호의 규정에 의거하여 제3자에게 배정.</span></p><p style="margin:0px 0px 0.75em;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;"><span style="font-size:16px;"></span></p><p style="margin:0px 0px 0.75em;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;"><span style="font-size:16px;"></span></p><p style="margin:0px 0px 0.75em;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;"> </p><p style="margin:0px 0px 0.75em;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;"><span style="font-size:16px;">2. 신주식 발행의 건</span></p><p style="margin:0px 0px 0.75em;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;"><span style="font-size:16px;">1) 신주식의 종류와 수 : 기명식 보통주식 237,500주<br /></span><span style="font-size:16px;">2) 1주의 액면금액 : 금500원<br /></span><span style="font-size:16px;">3) 1주의 발행가액 : 금 8,000원 <br /></span><span style="font-size:16px;">4) 신주 청약일 : 2026년 04월 30일 <br /></span><span style="font-size:16px;">5) 납 입 기 일 : 2026년 04월 30일 <br /></span><span style="font-size:16px;">6) 신주식의 인수방법 : 정관 제10조 2항 6호의 규정에 의거하여 제3자에게 배정.</span></p><p style="margin:0px 0px 0.75em;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;"> </p><p style="margin:0px 0px 0.75em;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;text-align:center;">2026년 04월 14일</p><p style="margin:0px 0px 0.75em;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;text-align:center;">주식회사 카인사이언스<br />경기도 성남시 분당구 대왕판교로 644번길 21, 3층</p><p style="margin:0px;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;text-align:center;">대표이사 조 대 호, 방 사 익</p>]]></description>
			<author><![CDATA[카인사이언스]]></author>
			<pubDate>Tue, 14 Apr 2026 07:26:44 +0000</pubDate>
			<category domain="https://info.kinesciences.com/?kboard_redirect=2"><![CDATA[IR]]></category>
		</item>
				<item>
			<title><![CDATA[제10기 정기주주총회 소집공고]]></title>
			<link><![CDATA[https://info.kinesciences.com/?kboard_content_redirect=126]]></link>
			<description><![CDATA[<p style="margin-right:0px;margin-bottom:0.75em;margin-left:0px;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;text-align:center;"><strong><span style="font-size:28px;">제10기 정기주주총회 소집공고</span></strong></p><p style="margin-right:0px;margin-bottom:0.75em;margin-left:0px;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;"> </p><p style="margin-right:0px;margin-bottom:0.75em;margin-left:0px;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;"><span style="font-size:16px;">주주님의 건승과 댁내의 평안을 기원합니다.</span></p><p style="margin-right:0px;margin-bottom:0.75em;margin-left:0px;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;"><span style="font-size:16px;">상법 제363조와 정관 제27조에 의거 정기주주총회를 아래와 같이 개최하오니 참석하여 주시기 바랍니다.</span></p><p style="margin-right:0px;margin-bottom:0.75em;margin-left:0px;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;text-align:center;">--- 아 래 ---</p><p style="margin-right:0px;margin-bottom:0.75em;margin-left:0px;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;"><strong><span style="font-size:16px;">1. 일시: 2026년 03월 31일(화요일) 오전 10시</span></strong></p><p style="margin-right:0px;margin-bottom:0.75em;margin-left:0px;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;"><strong><span style="font-size:16px;">2. 장소: 경기도 성남시 분당구 대왕판교로 644번길 21, 3F 주식회사 카인사이언스 대회의실</span></strong></p><p style="margin-right:0px;margin-bottom:0.75em;margin-left:0px;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;"><strong><span style="font-size:16px;">3. 회의 목적사항(부의 안건)</span></strong></p><p style="margin-right:0px;margin-bottom:0.75em;margin-left:0px;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;padding-left:40px;"><span style="font-size:16px;">제1호 의안 : 제10기(2025.01.01~2025.12.31) 재무제표 승인의 건</span></p><p style="margin-right:0px;margin-bottom:0.75em;margin-left:0px;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;padding-left:40px;"><span style="font-size:16px;">제2호 의안 : 이사 선임의 건</span></p><p style="margin-right:0px;margin-bottom:0.75em;margin-left:0px;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;padding-left:40px;"><span style="font-size:16px;">- 제2-1호 의안 : 사내이사 방사익 선임의 건(신규)</span></p><p style="margin-right:0px;margin-bottom:0.75em;margin-left:0px;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;padding-left:40px;"><span style="font-size:16px;">제3호 의안 : </span><span style="font-size:16px;">이사 보수한도 승인의 건</span></p><p style="margin-right:0px;margin-bottom:0.75em;margin-left:0px;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;padding-left:40px;"><span style="font-size:16px;">제4호 의안 : </span><span style="font-size:16px;">감사 보수한도 승인의 건</span></p><p style="margin-right:0px;margin-bottom:0.75em;margin-left:0px;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;"><span style="font-size:16px;"><strong>4. 주주총회 참석 시 준비물</strong></span></p><p style="margin-right:0px;margin-bottom:0.75em;margin-left:0px;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;padding-left:40px;"><span style="font-size:16px;">- 직접행사 : 주주총회 소집통지서, 신분증</span></p><p style="margin-right:0px;margin-bottom:0.75em;margin-left:0px;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;padding-left:40px;"><span style="font-size:16px;">- 대리행사 : 의결권 행사 위임장(주주와 대리인의 인적사항 기재, 인감날인), 대리인 신분증</span></p><p style="margin-right:0px;margin-bottom:0.75em;margin-left:0px;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;"> </p><p style="margin-right:0px;margin-bottom:0.75em;margin-left:0px;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;text-align:center;">2026년 03월 13일</p><p style="margin-right:0px;margin-left:0px;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;text-align:center;">(주)카인사이언스 대표이사 조대호</p>]]></description>
			<author><![CDATA[카인사이언스]]></author>
			<pubDate>Fri, 13 Mar 2026 07:12:49 +0000</pubDate>
			<category domain="https://info.kinesciences.com/?kboard_redirect=2"><![CDATA[IR]]></category>
		</item>
				<item>
			<title><![CDATA[[한국경제] 카인사이언스, '미니 단백질'로 근감소증 정조준]]></title>
			<link><![CDATA[https://info.kinesciences.com/?kboard_content_redirect=125]]></link>
			<description><![CDATA[<p> </p>
<p><a href="https://www.hankyung.com/article/2026010526861">출처 : 한국경제 - 카인사이언스, '미니 단백질'로 근감소증 정조준</a></p>]]></description>
			<author><![CDATA[카인사이언스]]></author>
			<pubDate>Tue, 06 Jan 2026 04:30:49 +0000</pubDate>
			<category domain="https://info.kinesciences.com/?kboard_redirect=1"><![CDATA[News]]></category>
		</item>
				<item>
			<title><![CDATA[주주명부폐쇄기간 또는 기준일 설정]]></title>
			<link><![CDATA[https://info.kinesciences.com/?kboard_content_redirect=124]]></link>
			<description><![CDATA[<p style="margin-right:0px;margin-bottom:0.75em;margin-left:0px;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;text-align:center;"><b><span style="font-size:24px;">제10기 정기주주총회 개최를 위한 권리주주 확정</span></b></p><p style="margin-right:0px;margin-bottom:0.75em;margin-left:0px;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;"></p><p style="margin-right:0px;margin-bottom:0.75em;margin-left:0px;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;text-align:center;line-height:1;"><span style="font-size:16px;">주주님의 건승과 댁네의 평안을 기원합니다.</span></p><p style="margin-right:0px;margin-bottom:0.75em;margin-left:0px;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;text-align:center;line-height:1;"><span style="font-size:16px;">상법 제 354조 및 당사 정관 제 20조에 의거 제10기 정기주주총회 소집을 위하여 주주확정 및 기준일 설정을</span></p><p style="margin-right:0px;margin-bottom:0.75em;margin-left:0px;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;text-align:center;line-height:1;"><span style="font-size:16px;">다음와 같이 공지하오니 양지하여주시기 바랍니다.</span></p><p style="margin-right:0px;margin-bottom:0.75em;margin-left:0px;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;text-align:center;"></p><p style="margin-right:0px;margin-bottom:0.75em;margin-left:0px;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;text-align:center;">- 다  음 - </p><p style="margin-right:0px;margin-bottom:0.75em;margin-left:0px;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;">1. 주주명부 확정기준일 : 2025년 12월 31일</p><p style="margin-right:0px;margin-bottom:0.75em;margin-left:0px;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;"></p><p style="margin-right:0px;margin-bottom:0.75em;margin-left:0px;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;"></p><p style="margin-right:0px;margin-bottom:0.75em;margin-left:0px;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;text-align:center;"></p><p style="margin-right:0px;margin-bottom:0.75em;margin-left:0px;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;text-align:center;"><span style="font-size:24px;"></span></p><p style="margin-right:0px;margin-bottom:0.75em;margin-left:0px;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;text-align:center;line-height:3;"><span style="font-size:24px;">2025년 12월 15일</span></p><p style="margin-right:0px;margin-left:0px;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;text-align:center;line-height:3;"><span style="font-size:24px;">카인사인언스 대표이사 조대호</span></p>]]></description>
			<author><![CDATA[카인사이언스]]></author>
			<pubDate>Mon, 15 Dec 2025 00:57:37 +0000</pubDate>
			<category domain="https://info.kinesciences.com/?kboard_redirect=2"><![CDATA[IR]]></category>
		</item>
				<item>
			<title><![CDATA[[더벨] 카인사이언스, 국가신약개발사업 과제 선정]]></title>
			<link><![CDATA[https://info.kinesciences.com/?kboard_content_redirect=123]]></link>
			<description><![CDATA[<p> </p>
<p><a href="https://www.thebell.co.kr/free/content/ArticleView.asp?key=202512040958330160107318">출처 : 더벨 - 카인사이언스, 국가신약개발사업 과제 선정</a></p>]]></description>
			<author><![CDATA[카인사이언스]]></author>
			<pubDate>Mon, 08 Dec 2025 06:09:54 +0000</pubDate>
			<category domain="https://info.kinesciences.com/?kboard_redirect=1"><![CDATA[News]]></category>
		</item>
				<item>
			<title><![CDATA[[메디칼타임즈] 카인사이언스, 국가신약개발사업 과제 선정…비임상 돌입]]></title>
			<link><![CDATA[https://info.kinesciences.com/?kboard_content_redirect=122]]></link>
			<description><![CDATA[<p> </p>
<p><a href="https://medicaltimes.com/Main/News/NewsView.html?ID=1166309">출처 : 메디칼타임즈 - 카인사이언스, 국가신약개발사업 과제 선정…비임상 돌입</a></p>]]></description>
			<author><![CDATA[카인사이언스]]></author>
			<pubDate>Mon, 08 Dec 2025 06:08:38 +0000</pubDate>
			<category domain="https://info.kinesciences.com/?kboard_redirect=1"><![CDATA[News]]></category>
		</item>
				<item>
			<title><![CDATA[[머니투데이] HK이노엔-카인사이언스, 근감소증 치료제 공동 개발·임상 2상 추진]]></title>
			<link><![CDATA[https://info.kinesciences.com/?kboard_content_redirect=121]]></link>
			<description><![CDATA[<p> </p>
<p><a href="https://www.mt.co.kr/thebio/2025/11/18/2025111809081520178">출처 : 머니투데이 - HK이노엔-카인사이언스, 근감소증 치료제 공동 개발·임상 2상 추진</a></p>]]></description>
			<author><![CDATA[카인사이언스]]></author>
			<pubDate>Mon, 08 Dec 2025 06:07:07 +0000</pubDate>
			<category domain="https://info.kinesciences.com/?kboard_redirect=1"><![CDATA[News]]></category>
		</item>
				<item>
			<title><![CDATA[[팜이데일리] HK이노엔·카인사이언스, 근감소증 치료제 공동 개발.. 국내 임상 2상 가속화]]></title>
			<link><![CDATA[https://info.kinesciences.com/?kboard_content_redirect=120]]></link>
			<description><![CDATA[<p> </p>
<p><a href="https://pharm.edaily.co.kr/News/Read?newsId=03158646642367032">출처 : 팜이데일리 - HK이노엔·카인사이언스, 근감소증 치료제 공동 개발.. 국내 임상 2상 가속화</a></p>]]></description>
			<author><![CDATA[카인사이언스]]></author>
			<pubDate>Mon, 08 Dec 2025 06:05:29 +0000</pubDate>
			<category domain="https://info.kinesciences.com/?kboard_redirect=1"><![CDATA[News]]></category>
		</item>
				<item>
			<title><![CDATA[[더벨] 카인사이언스, HK이노엔과 근감소증 치료제 공동 개발]]></title>
			<link><![CDATA[https://info.kinesciences.com/?kboard_content_redirect=119]]></link>
			<description><![CDATA[<p> </p>
<p><a href="https://www.thebell.co.kr/free/content/ArticleView.asp?key=202511181100397320108283">출처 : 더벨 - 카인사이언스, HK이노엔과 근감소증 치료제 공동 개발</a></p>]]></description>
			<author><![CDATA[카인사이언스]]></author>
			<pubDate>Mon, 08 Dec 2025 06:03:03 +0000</pubDate>
			<category domain="https://info.kinesciences.com/?kboard_redirect=1"><![CDATA[News]]></category>
		</item>
				<item>
			<title><![CDATA[[메디칼타임즈] HK이노엔-카인사이언스, 근감소증 치료제 임상 2상 추진]]></title>
			<link><![CDATA[https://info.kinesciences.com/?kboard_content_redirect=118]]></link>
			<description><![CDATA[<p> </p>
<p><a href="https://www.medicaltimes.com/Main/News/NewsView.html?ID=1166083">출처 : 메디칼타임즈 - HK이노엔-카인사이언스, 근감소증 치료제 임상 2상 추진</a></p>]]></description>
			<author><![CDATA[카인사이언스]]></author>
			<pubDate>Mon, 08 Dec 2025 06:00:33 +0000</pubDate>
			<category domain="https://info.kinesciences.com/?kboard_redirect=1"><![CDATA[News]]></category>
		</item>
				<item>
			<title><![CDATA[[이투데이] HK이노엔·카인사이언스, 근감소증 치료제 공동 개발 및 2상 추진]]></title>
			<link><![CDATA[https://info.kinesciences.com/?kboard_content_redirect=117]]></link>
			<description><![CDATA[<p> </p>
<p><a href="https://www.etoday.co.kr/news/view/2526745">출처 :  이투데이 - HK이노엔·카인사이언스, 근감소증 치료제 공동 개발 및 2상 추진</a></p>]]></description>
			<author><![CDATA[카인사이언스]]></author>
			<pubDate>Mon, 08 Dec 2025 05:58:34 +0000</pubDate>
			<category domain="https://info.kinesciences.com/?kboard_redirect=1"><![CDATA[News]]></category>
		</item>
				<item>
			<title><![CDATA[[바이오스펙테이터] HK이노엔, 카인과 "내년 2상" '근감소증 신약' 공동개발]]></title>
			<link><![CDATA[https://info.kinesciences.com/?kboard_content_redirect=116]]></link>
			<description><![CDATA[<p> </p>
<p><a href="">출처 : 바이오스펙테이터 - HK이노엔, 카인과 "내년 2상" '근감소증 신약' 공동개발</a></p>]]></description>
			<author><![CDATA[카인사이언스]]></author>
			<pubDate>Mon, 08 Dec 2025 05:54:12 +0000</pubDate>
			<category domain="https://info.kinesciences.com/?kboard_redirect=1"><![CDATA[News]]></category>
		</item>
				<item>
			<title><![CDATA[임시주주총회 소집공고]]></title>
			<link><![CDATA[https://info.kinesciences.com/?kboard_content_redirect=115]]></link>
			<description><![CDATA[<h4 style="font-family:'Noto Sans KR', sans-serif;color:rgb(27,33,26);text-align:center;"><span style="font-size:30px;">임시주주총회 소집공고</span></h4><h5 style="font-family:'Noto Sans KR', sans-serif;color:rgb(27,33,26);text-align:center;"><span style="font-size:18px;">주주님의 건승과 댁내의 평안을 기원합니다.<br /></span><span style="font-size:18px;">상법 제363조와 정관 제27조에 의거 임시주주총회를 아래와 같이 개최하오니 참석하여 주시기 바랍니다.<br /><br /></span><span style="font-size:18px;">--- 아 래 ---</span></h5><p style="margin-right:0px;margin-bottom:0.75em;margin-left:0px;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;padding-left:40px;"><span style="font-size:16px;">1. 일</span><span style="font-size:16px;">시 : 2025년 12월 01일(월요일) 오전 09시</span><br /><span style="font-size:16px;">2. 장소 : 서울특별시 강남구 언주로85길 24, 6F 주식회사 카인사이언스 본사 회의실</span><br /><span style="font-size:16px;">3. 회의 목적사항(부의 안건)</span><br /><span style="font-size:16px;">제1호 의안 : 정관 변경의 건(본점 소재지 변경)</span><span style="font-size:16px;"><br />4. 주주총회 참석 시 준비물</span><br /><span style="font-size:16px;">- 직접행사 : 신분증</span><br /><span style="font-size:16px;">- 대리행사 : 의결권 행사 위임장(주주와 대리인의 인적사항 기재, 인감날인), 대리인 신분증</span><br /><span style="font-size:16px;">5. </span><span style="font-size:16px;">전자증권제도 시행에 따른 실물증권 보유자의 권리 보호에 관한 사항</span><br /><span style="font-size:16px;">- <span style="font-family:'Noto Sans KR';">당사는 「주식·사채 등의 전자등록에 관한 법률」에 따라 전자증권제도 적용 대상 법인입니다. 주주총회에서 의결권을</span></span><br /><span style="font-size:16px;">행사하시고자 하는 주주께서는 명의개서대리인 KB은행에 실물 주권을 제출하시어 전자등록을 완료해야함을 안내드립니다.</span><span style="font-size:16px;"><br />미등록 주권에 대해서는 권리 행사가 제한될 수 있습니다.</span></p><p style="margin-right:0px;margin-bottom:0.75em;margin-left:0px;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;padding-left:40px;"><span style="font-size:16px;"></span></p><p style="margin-right:0px;margin-bottom:0.75em;margin-left:0px;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;padding-left:40px;"><span style="font-size:16px;"></span></p><p style="margin-right:0px;margin-bottom:0.75em;margin-left:0px;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;padding-left:40px;"></p><p style="margin-right:0px;margin-bottom:0.75em;margin-left:0px;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;text-align:center;"></p><p style="margin-right:0px;margin-bottom:0.75em;margin-left:0px;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;text-align:center;">　</p><p style="margin-right:0px;margin-bottom:0.75em;margin-left:0px;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;text-align:center;">2025년 11월 14일</p><p style="margin-right:0px;margin-bottom:0.75em;margin-left:0px;color:rgb(70,70,70);font-family:'Noto Sans KR', sans-serif;text-align:center;">(주)카인사이언스 대표이사 조대호</p>]]></description>
			<author><![CDATA[카인사이언스]]></author>
			<pubDate>Fri, 14 Nov 2025 00:47:12 +0000</pubDate>
			<category domain="https://info.kinesciences.com/?kboard_redirect=2"><![CDATA[IR]]></category>
		</item>
				<item>
			<title><![CDATA[임시주주총회 의결권 행사 주주확정을 위한 기준일 설정 공고]]></title>
			<link><![CDATA[https://info.kinesciences.com/?kboard_content_redirect=114]]></link>
			<description><![CDATA[<p style="text-align:center;"><b><span style="font-size:24px;">임시주주총회 소집을 위한 의결권 행사 주주확정 및 기준일 설정 공고</span></b></p><p><br /></p><p style="text-align:center;line-height:1;"><span style="font-size:16px;">주주님의 건승과 댁네의 평안을 기원합니다.</span></p><p style="text-align:center;line-height:1;"><span style="font-size:16px;">상법 제 363조 및 당사 정관 제 27조에 의거 임시주주총회 소집을 위하여 주주확정 및 기준일 설정을 </span></p><p style="text-align:center;line-height:1;"><span style="font-size:16px;">다음와 같이 공지하오니 양지하여주시기 바랍니다.</span></p><p style="text-align:center;"><span style="font-size:20px;"><br /></span></p><p style="text-align:center;"><span style="font-size:20px;">- 다  음 - </span></p><p style="text-align:left;"><span style="font-size:20px;">1. 주주명부 확정기준일 : 2025년 10월 31일</span></p><p style="text-align:left;"><span style="font-size:20px;"></span></p><p style="text-align:left;"><span style="font-size:20px;"></span></p><p style="text-align:center;"></p><p style="text-align:center;"><span style="font-size:24px;"></span></p><p style="text-align:center;line-height:3;"><span style="font-size:24px;">2025년 10월 16일</span></p><p style="text-align:center;line-height:3;"><span style="font-size:24px;">카인사인언스 대표이사 조대호</span></p>]]></description>
			<author><![CDATA[카인사이언스]]></author>
			<pubDate>Thu, 16 Oct 2025 02:27:36 +0000</pubDate>
			<category domain="https://info.kinesciences.com/?kboard_redirect=2"><![CDATA[IR]]></category>
		</item>
				<item>
			<title><![CDATA[[이데일리] 카인사이언스, 코스닥 상장 절차 본격화...2000억 대 가치 인정 받나]]></title>
			<link><![CDATA[https://info.kinesciences.com/?kboard_content_redirect=112]]></link>
			<description><![CDATA[<p> </p>
<p><a href="https://pharm.edaily.co.kr/News/Read?newsId=01275926642268304">출처 : 이데일리 - 카인사이언스, 코스닥 상장 절차 본격화...2000억 대 가치 인정 받나 </a></p>]]></description>
			<author><![CDATA[카인사이언스]]></author>
			<pubDate>Thu, 28 Aug 2025 05:04:22 +0000</pubDate>
			<category domain="https://info.kinesciences.com/?kboard_redirect=1"><![CDATA[News]]></category>
		</item>
				<item>
			<title><![CDATA[전자증권 전환 대상 주권 권리자(주주) 보호 및 조치사항 안내]]></title>
			<link><![CDATA[https://info.kinesciences.com/?kboard_content_redirect=111]]></link>
			<description><![CDATA[<p class="MsoNormal" style="line-height:1.4;"><span style="font-size:12pt;">2019. 9.16</span><span style="font-size:12pt;">일 「주식</span><span style="font-size:12pt;">·</span><span style="font-size:12pt;">사채 등의 전자등록에 관한 법률</span><span>(</span>이하 <span>“</span>전자증권법<span>”)</span><span style="font-size:12pt;">」이 시행됨에 따라 당사의 전자증권 전환 대상 주권 권리자를 보호하기 위하여 전자증권법 제<span>27</span>조<span> 1</span>항에 근거하여 아래의 사항을 통지합니다<span>.</span></span></p><p class="MsoNormal" style="text-align:center;line-height:1.4;"><span style="font-size:12pt;">– </span><span style="font-size:12pt;">아 래<br />
<span>–</span></span></p><p class="MsoNormal" style="margin-top:0cm;margin-right:0cm;margin-bottom:0cm;margin-left:16.8pt;text-indent:-16.8pt;line-height:16pt;"><b><span style="font-size:12pt;">1.</span></b><span style="font-size:12pt;"> </span><span style="font-size:12pt;">전자증권법 시행</span><span style="font-size:11pt;">(<span style="color:#FF0000;">2019.9.16</span>)</span><span style="font-size:12pt;"> </span><span style="font-size:12pt;">이후<span>, </span>당사 전자등록 시행 예정일</span><span style="font-size:11pt;">(<span style="color:#FF0000;">2025. 9.15</span>)</span><span style="font-size:12pt;">부터 주주<span>(</span>권리자<span>)</span>가<br />
소유중인 실물증권<span>(</span>전환 대상 주권<span>)</span>은 효력을 잃게 됩니다<span>.</span></span></p><p class="MsoNormal" style="margin-left:16.8pt;text-indent:-16.8pt;line-height:14pt;"><span style="font-size:12pt;"> </span></p><p class="MsoNormal" style="margin-top:0cm;margin-right:0cm;margin-bottom:0cm;margin-left:16.8pt;text-indent:-16.8pt;line-height:16pt;"><b><span style="font-size:12pt;">2.</span></b><span style="font-size:12pt;"> </span><span style="font-size:12pt;">따라서<span>, </span>주주</span><span style="font-size:11pt;">(</span><span style="font-size:11pt;">권리자<span>)</span></span><span style="font-size:12pt;">는 당사의 전자등록 시행 예정일 <span>5</span>영업일 전</span><span style="font-size:11pt;">(<span style="color:#FF0000;">2025. 9. 8</span>)</span><span style="font-size:12pt;">까지 증권회사 계좌<span>(</span>주식 등이 전자등록되는 전자등록계좌<span>)</span>를 통지하고 소유중인 실물증권<span>(</span>전환 대상 주권<span>)</span>을 제출해야 하며<span>, </span>방법은 아래와 같습니다<span>.</span></span></p><p class="MsoNormal" style="margin-left:16.8pt;text-indent:-16.8pt;line-height:14pt;"><span style="font-size:12pt;"> </span></p><p class="MsoNormal" style="margin-left:13.4pt;text-indent:-13.4pt;line-height:normal;"><span style="margin-left:15px;margin-top:236px;width:919px;height:270px;"></span><b><span style="font-size:12pt;"> </span></b><b><span style="font-size:12pt;">※ 주주 조치 사항<span></span></span></b></p><p class="MsoNormal" style="text-align:center;margin-left:16.1pt;text-indent:-16.1pt;line-height:normal;"><b><span style="font-size:12pt;">  </span></b><img src="data:image/png;base64,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" style="width:614px;" alt="8LTpx0j5PEjqgAAAAASUVORK5CYII=" /></p><p class="MsoNormal" style="margin-left:16.1pt;text-indent:-16.1pt;line-height:normal;"><b><span style="font-size:12pt;">3.</span></b><span style="font-size:12pt;"> </span><span style="font-size:12pt;">당사<span>(</span>발행인<span>)</span>는 전자등록 시행일</span><span style="font-size:11pt;color:#FF0000;">(2025</span><span style="font-size:11pt;color:#FF0000;">년 <span>9</span>월 <span>15</span>일<span>)</span></span><span style="font-size:12pt;"> </span><span style="font-size:12pt;">직전 영업일의<br />
주주명부에 기재된 권리자를 기준으로 전자등록이 되도록 전자등록기관<span>(</span>한국예탁결제원<span>)</span>에 요청할 예정입니다<span>.</span></span></p><p class="MsoNormal" style="text-align:center;line-height:normal;"><b><span style="font-size:12pt;">2025</span></b><b><span style="font-size:12pt;">년 <span>8</span>월 <span>11</span>일<span></span></span></b></p><p class="MsoNormal" style="text-align:center;"><b><span style="font-size:14pt;line-height:107%;">주식회사 카인사이언스<span></span></span></b></p><p style="text-align:center;"><b><span style="font-size:14pt;line-height:107%;font-family:'맑은 고딕';">대표이사 조 대 호</span></b></p>]]></description>
			<author><![CDATA[카인사이언스]]></author>
			<pubDate>Mon, 11 Aug 2025 05:47:50 +0000</pubDate>
			<category domain="https://info.kinesciences.com/?kboard_redirect=2"><![CDATA[IR]]></category>
		</item>
				<item>
			<title><![CDATA[[머니투데이] 카인사이언스, '파이프라인 부자'…"환자임상 성공, 기술이전 기대"]]></title>
			<link><![CDATA[https://info.kinesciences.com/?kboard_content_redirect=110]]></link>
			<description><![CDATA[<p> </p>
<p><a href="https://news.mt.co.kr/mtview.php?no=2025071615533332734">출처 : 머니투데이 - 카인사이언스, '파이프라인 부자'…"환자임상 성공, 기술이전 기대"</a></p>]]></description>
			<author><![CDATA[카인사이언스]]></author>
			<pubDate>Fri, 18 Jul 2025 01:42:15 +0000</pubDate>
			<category domain="https://info.kinesciences.com/?kboard_redirect=1"><![CDATA[News]]></category>
		</item>
				<item>
			<title><![CDATA[통일주권 발행을 위한 사전준비 서류 안내의 건]]></title>
			<link><![CDATA[https://info.kinesciences.com/?kboard_content_redirect=109]]></link>
			<description><![CDATA[<p><span style="font-size:16px;">１. 당사는 현재 한국거래소 코스닥 시장 상장을 위하여 상장 준비 작업을 진행하고 있습니다.<br /></span><span style="font-size:16px;">２. 거래소 상장예정회사는 명의개서 대리인을 선임 후 통일주권을 발행하는 절차가 필수적인 바, 업무 진행을 위하여 다음과 같이 주주분들께 필요서류를 안내해 드립니다.</span></p>
<p><strong>[제출서류 및 제출기한]</strong></p>
<ul>
<li style="list-style-type:none;">
<ol>
<li>
<div><b>통일주권 발행 일시 : 2025.07.10(목) 예정</b></div>
</li>
<li>
<div><b>제출서류<br /></b><span style="font-size:16px;"><b>가. 주주신분증 사본 1부 (법인인 경우 사업자등록증 / 조합인 경우 업무집행조합원의 사업자 등록증 혹은 신분증)<br /></b></span><span style="font-size:16px;">※ 주주분이 미성년자인 경우, 주주 기준 기본증명서(상세), 가족관계증명서(상세), 부모님 신분증<br /></span><span style="font-size:16px;"><b>나. 증권계좌(카드) or 계좌개설 확인서 1부<br /></b></span><span style="font-size:16px;">※ 증권카드 및 계좌개설 확인서는 종합위탁관리 계좌 (일반 증권계좌)를 요청드립니다.<br /></span><span style="font-size:16px;">      CMA 나 IS 계좌는 통일주권이 들어가지 않습니다.<br /></span><b style="font-size:16px;">다. 주권 미발행확인서 원본</b></div>
</li>
<li>
<div><b>1차 제출기한 : 2025. 07.09(수)까지 </b></div>
</li>
<li>
<div><b>우편 또는 이메일 제출</b>
<div><span style="font-size:16px;"><b>가. 우편 보내실 주소 : 서울특별시 강남구 언주로 85길24, 6층(역삼동, PNM빌딩) 경영관리팀 김정훈 과장<br /></b></span><span style="font-size:16px;"><b>나. 이메일 제출 : kjh0709@kinesciences.com 으로 회신</b></span></div>
</div>
</li>
</ol>
</li>
</ul>
<p><span style="font-size:16px;">상기 업무와 관련하여 문의사항이 있으신 경우 담당자에게 연락주시기 바랍니다.</span><br /><span style="font-size:16px;">담당자 : 경영관리팀 김정훈 과장</span><br /><span style="font-size:16px;">연락처 : 070-4243-9634, kjh0709@kinesciences.com. 끝.<br /><br /></span></p>
<p style="text-align:center;">2025년 07월 01일</p>
<p style="text-align:center;">주식회사 카인사이언스<br />서울특별시 강남구 언주로85길 24, 6층(역삼동)</p>
<p style="text-align:center;">대표이사 조 대 호</p>]]></description>
			<author><![CDATA[카인사이언스]]></author>
			<pubDate>Tue, 01 Jul 2025 00:58:47 +0000</pubDate>
			<category domain="https://info.kinesciences.com/?kboard_redirect=2"><![CDATA[IR]]></category>
		</item>
			</channel>
</rss>